Public Profile

Fisher Clinical Services, Inc.

Fisher Clinical Services, Inc., a prominent player in the clinical supply chain management industry, is headquartered in the United States. Founded in 2003, the company has established itself as a leader in providing comprehensive clinical trial services, including packaging, storage, and distribution of investigational medicinal products. With operational facilities strategically located across North America and Europe, Fisher Clinical Services ensures efficient and compliant supply solutions for pharmaceutical and biotechnology companies. The company is renowned for its innovative approach to clinical supply management, offering tailored services that enhance trial efficiency and patient safety. Notable achievements include a robust portfolio of successful partnerships with leading global organisations, positioning Fisher Clinical Services as a trusted partner in the clinical research landscape. Their commitment to quality and regulatory compliance sets them apart in a competitive market, making them a preferred choice for clients seeking reliable clinical supply solutions.

DitchCarbon Score

How does Fisher Clinical Services, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

49

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Fisher Clinical Services, Inc.'s score of 49 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.

82%

Let us know if this data was useful to you

Fisher Clinical Services, Inc.'s reported carbon emissions

Fisher Clinical Services, Inc., headquartered in the US, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting on its carbon footprint. In the context of the industry, many companies are increasingly focusing on sustainability and setting ambitious targets to reduce their carbon emissions across all scopes. As Fisher Clinical Services progresses, it may consider establishing measurable goals to align with industry standards and contribute to global climate efforts.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Fisher Clinical Services, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Fisher Clinical Services, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Fisher Clinical Services, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers